Abstract
Recent studies indicate that individual blood–brain transport characteristics of phenylalanine may lead to different clinical outcomes in phenylketonuria (PKU) patients in spite of comparable dietary control. To check these preliminary data, we investigated four pairs of siblings with classical PKU (and identical genotype) using in vivo nuclear magnetic resonance spectroscopy in the course of an oral phenylalanine load (100 mg/kg body weight). Patients' brain phenylalanine concentrations were different in spite of similar blood levels. Interindividual variations of the apparent transport Michaelis constant, K t,app, ranged from 0.10 to 0.84 mmol/L. The ratio of the maximal transport velocity, T max, over the intracerebral consumption rate, V met, varied between 2.61 and 14.0. Siblings with lower values for K t,app, higher values for T max/V met, and higher concurrent brain phenylalanine levels showed a lower IQ and a higher degree of cerebral white matter abnormalities. The results indicate that blood–brain barrier transport characteristics and the resultant brain phenylalanine levels are causative factors for the individual clinical outcome in PKU.
Similar content being viewed by others
REFERENCES
Knudsen GM, Hasselbalch S, Toft PB, Christensen E, Paulson OB, Lou H (1995) Blood-brain barrier transport of amino acids in healthy controls and patients with phenylketonuria. J Inherit Metab Dis 18: 653-664.
Koch R, Moats R, Guttler F, Guldberg P, Nelson M (2000) Blood-brain phenylalanine relationships in persons with phenylketonuria. Pediatrics 106: 1093-1096.
Müller HE, Vermathen P, Ullrich K, Weglage J, Koch HG, Peters PE (1995) In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment. Neuropediatrics 26: 199-202.
Müller HE, Weglage J, Wiedermann D, Ullrich K (1998) Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab 18: 1184-1191.
Rupp A, Kreis R, Zschocke J, et al (2001) Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria. J Cereb Blood Flow Metab 21: 276-284.
Scriver CH, Kaufman S, Eisensmith RC, Woo SLC (2001) The hyperphenylalaninemias. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw Hill, 1667-1724.
Weglage J, Wiedermann D, Denecke J, et al (2001) Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol 50: 463-467.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weglage, J., Wiedermann, D., Denecke, J. et al. Individual blood–brain barrier phenylalanine transport in siblings with classical phenylketonuria. J Inherit Metab Dis 25, 431–436 (2002). https://doi.org/10.1023/A:1021234730512
Issue Date:
DOI: https://doi.org/10.1023/A:1021234730512